| Literature DB >> 30532267 |
Fernando Vaquerizo-Villar1, Daniel Álvarez1,2, Leila Kheirandish-Gozal3, Gonzalo C Gutiérrez-Tobal1, Verónica Barroso-García1, Andrea Crespo1,2, Félix Del Campo1,2, David Gozal3, Roberto Hornero1,4.
Abstract
BACKGROUND: The gold standard for pediatric sleep apnea hypopnea syndrome (SAHS) is overnight polysomnography, which has several limitations. Thus, simplified diagnosis techniques become necessary.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30532267 PMCID: PMC6286069 DOI: 10.1371/journal.pone.0208502
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical characteristics of the patient groups under study.
| All | Optimization set | Cross-validation set | |
|---|---|---|---|
| 981 | 589 | 392 | |
| 6 [3–9] | 6 [3–8] | 6 [3–9] | |
| 602 (61.4%) | 347 (58.9%) | 255 (65.1%) | |
| 17.9 | 17.6 | 18.1 | |
| 3.8 [1.5–9.3] | 4.1 [1.7–9.9] | 3.3 [1.4–7.8] | |
| 576 (58.7%) | 330 (56.0%) | 246 (62.8%) | |
| 405 (41.3%) | 259 (44.0%) | 146 (37.2%) |
BMI: Body Mass Index; AHI: Apnea Hypopnea Index. Data are presented as median [interquartile range] or n (%)
Fig 1Validation approach employed in each methodological step of the study.
Fig 2DWT computation.
(A) Decomposition process of a signal using DWT. (B) Original SpO2 signal, detail signals at each decomposition level and approximation signal at the maximum level of the decomposition.
Fig 3Histogram of the D9 coefficients for each group in the optimization set.
DWT-derived features for each group in the optimization set.
| Feature | Group AHI <5 e/h | Group AHI ≥5 e/h | |
|---|---|---|---|
| 3.04 [2.26 3.92] | 5.36 [3.77 7.70] | ||
| 3.78 [3.23 4.63] | 5.73 [4.30 7.57] | ||
| 1.31 [1.20 1.44] | 1.19 [1.06 1.32] | ||
| 3.58 [1.03 7.69] | 0.06 [0.04 2.69] | ||
| 1.23 [1.04 1.55] | 1.96 [1.42 2.62] | ||
| 0.54 [0.37 0.89] | 1.54 [0.78 2.96] | ||
| 1.83 [1.18 2.86] | 4.27 [2.52 9.41] |
Diagnostic ability of the proposed features (ODI3, statistical moments, PSD, and DWT) in the cross-validation set.
| Feature | Se (%) | Sp (%) | PPV (%) | NPV (%) | LR+ | LR- | Acc (%) |
|---|---|---|---|---|---|---|---|
| 78.1±7.3 | 84.2±8.1 | 75.2±10.2 | 86.5±5.0 | 6.1±2.9 | 0.27±0.11 | 81.9±7.2 | |
| 62.3±6.8 | 65.0±2.6 | 51.4±2.1 | 74.6±3.6 | 1.8±0.2 | 0.58±0.10 | 64.0±2.3 | |
| 72.6±13.6 | 67.1±6.6 | 56.7±2.8 | 81.2±6.6 | 2.2±0.3 | 0.40±0.17 | 69.2±3.1 | |
| 65.0±8.5 | 61.4±6.8 | 50.1±2.8 | 74.9±2.8 | 1.7±0.2 | 0.57±0.09 | 62.7±2.7 | |
| 60.9±15.6 | 49.9±8.4 | 41.6±5.0 | 69.0±7.5 | 1.2±0.3 | 0.78±0.26 | 54.0±5.2 | |
| 75.3±7.9 | 82.5±7.4 | 73.0±8.5 | 85.1±3.5 | 5.3±3.1 | 0.30±0.08 | 79.9±3.8 | |
| 69.8±7.3 | 83.4±5.2 | 71.8±6.2 | 82.5±3.0 | 4.5±1.4 | 0.36±0.08 | 78.3±3.2 | |
| 47.2±11.7 | 58.1±11.9 | 40.4±4.1 | 65.0±2.8 | 1.2±0.2 | 0.91±0.12 | 54.1±4.5 | |
| 63.6±8.3 | 47.1±6.2 | 41.7±4.2 | 68.7±6.1 | 1.2±0.2 | 0.79±0.23 | 53.3±5.0 | |
| 78.1±8.8 | 75.2±9.9 | 66.2±6.9 | 85.6±3.6 | 3.5±1.1 | 0.29±0.09 | 76.3±4.3 | |
| 48.6±14.4 | 61.8±11.8 | 43.0±4.8 | 67.3±3.3 | 1.3±0.3 | 0.82±0.12 | 56.9±4.2 | |
| 73.4±9.1 | 82.6±7.8 | 72.2±10.2 | 84.0±5.1 | 5.2±2.7 | 0.32±0.12 | 79.1±6.2 | |
| 74.7±6.1 | 81.7±6.5 | 71.5±6.9 | 84.6±3.0 | 4.6±1.7 | 0.31±0.07 | 79.1±3.3 | |
| 58.3±9.2 | 63.4±6.5 | 48.7±3.1 | 72.1±3.3 | 1.6±0.2 | 0.66±0.10 | 61.5±3.2 | |
| 71.2±6.7 | 64.6±5.7 | 54.6±3.3 | 79.2±4.0 | 2.0±0.3 | 0.45±0.10 | 67.1±3.5 | |
| 75.4±7.1 | 85.4±6.8 | 76.0±9.0 | 85.4±4.3 | 6.2±2.8 | 0.29±0.10 | 81.7±5.6 | |
| 78.8±4.4 | 81.7±5.2 | 72.2±5.5 | 86.7±2.4 | 4.6±1.4 | 0.26±0.05 | 80.6±3.4 | |
| 76.0±8.2 | 78.4±5.6 | 68.0±3.8 | 84.9±3.5 | 3.6±0.7 | 0.30±0.09 | 77.6±2.5 |
Diagnostic ability of the LR, SVM, and MLP models in the cross-validation set.
| Feature | Se (%) | Sp (%) | PPV (%) | NPV (%) | LR+ | LR- | Acc (%) |
|---|---|---|---|---|---|---|---|
| 72.6±4.7 | 90.2±6.2 | 82.3±8.8 | 84.7±2.8 | 9.8±5.5 | 0.31±0.06 | 83.7±4.9 | |
| 71.9±4.4 | 91.1±7.2 | 83.8±10.8 | 84.5±2.6 | 14.6±12.9 | 0.31±0.06 | 84.0±5.2 | |
| 73.3±6.6 | 89.0±6.9 | 80.7±9.2 | 84.9±3.3 | 9.0±5.8 | 0.30±0.08 | 83.2±5.2 |
Summary of the state-of-the-art studies in the context of detection of moderate-to-severe pediatric SAHS using SpO2 recordings.
| Studies | Subjects (n) | Methods | Validation | Se (%) | Sp (%) | Acc (%) |
|---|---|---|---|---|---|---|
| 58 | Direct validation | 67.0 | 60.0 | 64.0 | ||
| 148 | No | 83.8 | 86.5 | 85.1 | ||
| 141 | Direct validation | 60.0 | 86.0 | 72.0 | ||
| 268 | Clusters of desaturations and clinical history | Direct validation | 40.6 | 97.9 | 69.4 | |
| 50 | Statistical moments, spectral, nonlinear features, and classical indices | Bootstrap 0.632 | 82.2 | 83.6 | 82.8 | |
| 298 | Bispectrum, PSD, | Feature optimization- training-test | 61.8 | 97.6 | 81.3 | |
| 4191 | Statistical moments, PSD, nonlinear features, and | Training-test | 68.2 | 87.2 | 81.7 | |
| 981 | Optimization- cross validation | 71.9 | 91.1 | 84.0 |
* Computed from reported data
** Direct validation of a scoring criteria against AHI from PSG.